TORONTO (AP) — TORONTO (AP) — COSCIENS Biopharma Inc. (CSCI) on Wednesday reported a loss of $6.7 million in its fourth quarter.
The Toronto-based company said it had a loss of $2.15 per share.
The drug developer posted revenue of $3.3 million in the period.
For the year, the company reported a loss of $15.3 million, or $5.93 per share. Revenue was reported as $9.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CSCI at https://www.zacks.com/ap/CSCI
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
